Inveready Technology Investment Group
204
3M
158
12.75
70
0.22
27
- Stages of investment
- Areas of investment
Summary
In 2008 was created Inveready Technology Investment Group, which is appeared as VC. The leading representative office of defined VC is situated in the Barcelona. The company was established in Europe in Spain.
The higher amount of exits for fund were in 2019. The fund is constantly included in 7-12 investment rounds annually. This Inveready Technology Investment Group works on 13 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 27 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars.
The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Spain. Among the most popular portfolio startups of the fund, we may highlight Minoryx Therapeutics, Bitext, SamyRoad.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Inveready Technology Investment Group, startups are often financed by Wayra, The Crowd Angel, Media Digital Ventures. The meaningful sponsors for the fund in investment in the same round are Sabadell Venture Capital, Bankinter, The Crowd Angel. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Caixa Capital Risc, Media Digital Ventures.
The overall number of key employees were 11.
Investments analytics
Analytics
- Total investments
- 204
- Lead investments
- 70
- Exits
- 27
- Rounds per year
- 12.75
- Follow on index
- 0.22
- Investments by industry
- Software (53)
- Biotechnology (41)
- Health Care (33)
- Information Technology (24)
- Pharmaceutical (21) Show 210 more
- Investments by region
-
- Spain (172)
- United States (11)
- Canada (2)
- United Kingdom (7)
- France (3) Show 3 more
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.59
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.91
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Gretel.co | 01 Feb 2023 | Software | Seed | 550K | |
| Innerva Pharmaceuticals | 31 Oct 2022 | Biotechnology, Medical, Pharmaceutical | Seed | 2M | Barcelona, Catalonia, Spain |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.